Review





Similar Products

97
Cell Signaling Technology Inc anti β tubulin
Anti β Tubulin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/beta-Tubulin+Antibody/pm42966053-71-15-16
Average 97 stars, based on 1 article reviews
anti β tubulin - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
Novus Biologicals rat monoclonal anti alpha tubulin
Rat Monoclonal Anti Alpha Tubulin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/alpha+Tubulin+Antibody+(YL1%2F2)+-+BSA+Free/pmc13733432-1222-0-5
Average 94 stars, based on 1 article reviews
rat monoclonal anti alpha tubulin - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc β tubulin
HucMSC-sEV Delivers CERS1 to S12 Cells and HPV16-positive ectocervical organoids (A) Schematic diagram of de novo and salvage ceramide synthesis pathways, highlighting the role of CERS1 in regulating C18 ceramide synthesis (B) Western blot analysis of CERS1 expression in hucMSCs, hucMSC-sEV, and sEV free CM. (C, D) RT-qPCR analysis of CERS1 mRNA expression in (C) S12 cells and (D) HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL), respectively. (n = 3 biological repeats for each group, One-way ANOVA). (E, F) Representative Western blot images and quantitative analysis of CERS1 protein expression in S12 cells treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL). (n = 3 biological repeats for each group, One-way ANOVA). (G, H) Representative Western blot images and quantitative analysis of CERS1 protein expression in HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL). (n = 3 biological repeats for each group, One-way ANOVA). (I) Representative immunofluorescence images of CD63 (Green) and CERS1 (Yellow) colocalisation in S12 cells treated with 30 μg/mL hucMSC-sEV; nuclei are labelled with DAPI (blue). (Scale bar = 20 μm). (J) Representative immunofluorescence images of CD63 (Green) and CERS1 (Yellow) colocalisation in HPV16-posititve ectocervical organoids (A0X) treated with 30 μg/mL hucMSC-sEV; nuclei are labelled with DAPI (blue). (Scale bar = 20 μm). (K, L) Representative immunofluorescence images and corresponding MFI quantification of CERS1 (red) in S12 cells treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL); nuclei counterstained with DAPI (blue). (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA). (M, N) Representative immunofluorescence images and corresponding MFI quantification of CERS1 (red) in HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL); nuclei counterstained with DAPI (blue). (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA).All data are mean ± SD; In all bar charts, each dot represents one data point; Error bars represent SDs; *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001, ns: no significant.
β Tubulin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/beta-Tubulin+Antibody/pmc13753597-268-55-58
Average 97 stars, based on 1 article reviews
β tubulin - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Proteintech α tubulin
( A ) Schematic diagram of generation of Kat5 d/d mTSCs. The graphic elements were created in BioRender. Wang, F. (2026) https://BioRender.com/k48v0o5 . ( B ) Immunoblot analysis of KAT5 in mTSCs treated with or without Dox for 48 h in Kat5 f/f and Kat5 d/d cells. −Dox indicates untreated controls; +Dox indicates Kat5 depletion. ( C ) Cell counting of mTSCs treated with or without Dox for 48 hours. Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ***P < 0.001. Source data are provided as a source data file. ( D ) Volcano plot of differentially expressed genes (DEGs) ( P < 0.05, log 2 FC ≥ 0.5) in Kat5 f/f and Kat5 d/d mTSCs. ( E ) GO analysis of the top 150 down-regulated DEGs from (D) using DAVID. ( F ) GSEA showing enrichment of chromosome segregation and alignment gene sets in Kat5 d/d mTSCs. ( G ) Immunofluorescent staining of <t>α-tubulin</t> and Lamin A/C in Kat5 f/f and Kat5 d/d mTSCs. Arrows indicate misaligned chromosomes (left) and micronuclei (right). Quantification of metaphase cells with misaligned chromosomes and cells with micronuclei is shown (right). Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ***P < 0.001 and **P < 0.01, respectively. ( H to K ) Immunofluorescence staining and quantification of chromosome misalignment and micronuclei in Kat5 f/f , Kat5 d/d , H2az1 f/f , and H2az1 4M embryos at E5.0 to E5.5. Arrows indicate chromosome misalignment or micronuclei. Quantification was performed in CDX2 + cells ( n = 5 embryos per group for chromosome misalignment; n = 3 embryos per group for micronuclei). Two-tailed unpaired Student’s t test. Error bars, means ± SEM. **P < 0.01, *** P < 0.001.
α Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/alpha+Tubulin+Antibody/pmc13693675-211-24-25
Average 96 stars, based on 1 article reviews
α tubulin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech rabbit anti α tubulin
( A ) Schematic diagram of generation of Kat5 d/d mTSCs. The graphic elements were created in BioRender. Wang, F. (2026) https://BioRender.com/k48v0o5 . ( B ) Immunoblot analysis of KAT5 in mTSCs treated with or without Dox for 48 h in Kat5 f/f and Kat5 d/d cells. −Dox indicates untreated controls; +Dox indicates Kat5 depletion. ( C ) Cell counting of mTSCs treated with or without Dox for 48 hours. Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ***P < 0.001. Source data are provided as a source data file. ( D ) Volcano plot of differentially expressed genes (DEGs) ( P < 0.05, log 2 FC ≥ 0.5) in Kat5 f/f and Kat5 d/d mTSCs. ( E ) GO analysis of the top 150 down-regulated DEGs from (D) using DAVID. ( F ) GSEA showing enrichment of chromosome segregation and alignment gene sets in Kat5 d/d mTSCs. ( G ) Immunofluorescent staining of <t>α-tubulin</t> and Lamin A/C in Kat5 f/f and Kat5 d/d mTSCs. Arrows indicate misaligned chromosomes (left) and micronuclei (right). Quantification of metaphase cells with misaligned chromosomes and cells with micronuclei is shown (right). Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ***P < 0.001 and **P < 0.01, respectively. ( H to K ) Immunofluorescence staining and quantification of chromosome misalignment and micronuclei in Kat5 f/f , Kat5 d/d , H2az1 f/f , and H2az1 4M embryos at E5.0 to E5.5. Arrows indicate chromosome misalignment or micronuclei. Quantification was performed in CDX2 + cells ( n = 5 embryos per group for chromosome misalignment; n = 3 embryos per group for micronuclei). Two-tailed unpaired Student’s t test. Error bars, means ± SEM. **P < 0.01, *** P < 0.001.
Rabbit Anti α Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/alpha+Tubulin+Antibody/pm42905836-301-21-25
Average 96 stars, based on 1 article reviews
rabbit anti α tubulin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech β tubulin
IL‐35 Subunit EBI3 is Downregulated in both Obese Mouse Aortas and PA‐Treated HUVECs, and Restored by Exogenous IL‐35. (A, B) Immunofluorescence of EBI3 (red) with CD31 (green) and DAPI (blue) in mouse aortas, with semi‐quantification of fluorescence intensity, n = 3 (scale bar = 50 µM). (C, D) Immunofluorescence of IL‐12A (red) with CD31 (green) and DAPI (blue) in mouse aortas, with semi‐quantification of fluorescence intensity, n = 3 (scale bar = 50 µM). (E) Serum IL‐35 concentrations, n = 8. (F, H) Representative Western blot bands of EBI3 and IL‐12A in aortic tissues (F) and densitometric analysis (H, n = 4). (G, I) Representative Western blot bands of EBI3 and IL‐12A in HUVECs (G) and densitometric analysis (I, n = 4). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
β Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/beta+Tubulin+Antibody/pmc13689533-35-21-24
Average 96 stars, based on 1 article reviews
β tubulin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Novus Biologicals tubulin α8
Clinical significance of the TUBB2A and TUBB3 target genes in breast cancer patients. ( A ) Kaplan–Meier plots correlating gene-chip mRNA expression of TUBB2A and TUBB3 to the survival of breast cancer patients ( n = 4929). High expression of both isotypes was associated with worse survival ( TUBB2A , HR 1.39; TUBB3 , HR 1.57). Plots were generated using KM Plotter ( https://kmplot.com/analysis/ , accessed on 20 January 2026), including all breast cancer subtypes without restriction by treatment. Patients stratified at the median. ( B ) Immunohistochemistry of normal human mammary gland tissue sections, stained for <t>tubulin</t> β2 and β3. Strong β2 staining but not β3 was observed in the epithelial lining cells of the mammary ducts. Representative of 5 images per marker. Images captured at 40×, scale bar 50 µm. ( C ) Expression of TUBB2A and TUBB3 (log 2 [TPM + 1]) in BRCA tumors (red) versus normal (blue) breast tissue. Tumor samples demonstrated significant downregulation of TUBB2A and upregulation of TUBB3 ( n = 1093 tumor, n = 112 normal; *** p < 0.001). Analyzed using TIMER2.0 ( http://timer.cistrome.org/ , accessed on 14 January 2026). TPM: Transcripts per million.
Tubulin α8, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/Tubulin+alpha-8+Antibody+(2D6)+-+BSA+Free/pmc13761978-39-33-36
Average 94 stars, based on 1 article reviews
tubulin α8 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc rabbit anti β tubulin
Clinical significance of the TUBB2A and TUBB3 target genes in breast cancer patients. ( A ) Kaplan–Meier plots correlating gene-chip mRNA expression of TUBB2A and TUBB3 to the survival of breast cancer patients ( n = 4929). High expression of both isotypes was associated with worse survival ( TUBB2A , HR 1.39; TUBB3 , HR 1.57). Plots were generated using KM Plotter ( https://kmplot.com/analysis/ , accessed on 20 January 2026), including all breast cancer subtypes without restriction by treatment. Patients stratified at the median. ( B ) Immunohistochemistry of normal human mammary gland tissue sections, stained for <t>tubulin</t> β2 and β3. Strong β2 staining but not β3 was observed in the epithelial lining cells of the mammary ducts. Representative of 5 images per marker. Images captured at 40×, scale bar 50 µm. ( C ) Expression of TUBB2A and TUBB3 (log 2 [TPM + 1]) in BRCA tumors (red) versus normal (blue) breast tissue. Tumor samples demonstrated significant downregulation of TUBB2A and upregulation of TUBB3 ( n = 1093 tumor, n = 112 normal; *** p < 0.001). Analyzed using TIMER2.0 ( http://timer.cistrome.org/ , accessed on 14 January 2026). TPM: Transcripts per million.
Rabbit Anti β Tubulin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/beta-Tubulin+Antibody/pm42971042-151-0-4
Average 97 stars, based on 1 article reviews
rabbit anti β tubulin - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

96
Proteintech anti α tubulin
Clinical significance of the TUBB2A and TUBB3 target genes in breast cancer patients. ( A ) Kaplan–Meier plots correlating gene-chip mRNA expression of TUBB2A and TUBB3 to the survival of breast cancer patients ( n = 4929). High expression of both isotypes was associated with worse survival ( TUBB2A , HR 1.39; TUBB3 , HR 1.57). Plots were generated using KM Plotter ( https://kmplot.com/analysis/ , accessed on 20 January 2026), including all breast cancer subtypes without restriction by treatment. Patients stratified at the median. ( B ) Immunohistochemistry of normal human mammary gland tissue sections, stained for <t>tubulin</t> β2 and β3. Strong β2 staining but not β3 was observed in the epithelial lining cells of the mammary ducts. Representative of 5 images per marker. Images captured at 40×, scale bar 50 µm. ( C ) Expression of TUBB2A and TUBB3 (log 2 [TPM + 1]) in BRCA tumors (red) versus normal (blue) breast tissue. Tumor samples demonstrated significant downregulation of TUBB2A and upregulation of TUBB3 ( n = 1093 tumor, n = 112 normal; *** p < 0.001). Analyzed using TIMER2.0 ( http://timer.cistrome.org/ , accessed on 14 January 2026). TPM: Transcripts per million.
Anti α Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/alpha+Tubulin+Antibody/pm42901113-45-45-52
Average 96 stars, based on 1 article reviews
anti α tubulin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Proteintech anti β tubulin
Clinical significance of the TUBB2A and TUBB3 target genes in breast cancer patients. ( A ) Kaplan–Meier plots correlating gene-chip mRNA expression of TUBB2A and TUBB3 to the survival of breast cancer patients ( n = 4929). High expression of both isotypes was associated with worse survival ( TUBB2A , HR 1.39; TUBB3 , HR 1.57). Plots were generated using KM Plotter ( https://kmplot.com/analysis/ , accessed on 20 January 2026), including all breast cancer subtypes without restriction by treatment. Patients stratified at the median. ( B ) Immunohistochemistry of normal human mammary gland tissue sections, stained for <t>tubulin</t> β2 and β3. Strong β2 staining but not β3 was observed in the epithelial lining cells of the mammary ducts. Representative of 5 images per marker. Images captured at 40×, scale bar 50 µm. ( C ) Expression of TUBB2A and TUBB3 (log 2 [TPM + 1]) in BRCA tumors (red) versus normal (blue) breast tissue. Tumor samples demonstrated significant downregulation of TUBB2A and upregulation of TUBB3 ( n = 1093 tumor, n = 112 normal; *** p < 0.001). Analyzed using TIMER2.0 ( http://timer.cistrome.org/ , accessed on 14 January 2026). TPM: Transcripts per million.
Anti β Tubulin, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+a+tubulin+antibody/beta+Tubulin+Antibody/pmc13693545-82-34-37
Average 96 stars, based on 1 article reviews
anti β tubulin - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


HucMSC-sEV Delivers CERS1 to S12 Cells and HPV16-positive ectocervical organoids (A) Schematic diagram of de novo and salvage ceramide synthesis pathways, highlighting the role of CERS1 in regulating C18 ceramide synthesis (B) Western blot analysis of CERS1 expression in hucMSCs, hucMSC-sEV, and sEV free CM. (C, D) RT-qPCR analysis of CERS1 mRNA expression in (C) S12 cells and (D) HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL), respectively. (n = 3 biological repeats for each group, One-way ANOVA). (E, F) Representative Western blot images and quantitative analysis of CERS1 protein expression in S12 cells treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL). (n = 3 biological repeats for each group, One-way ANOVA). (G, H) Representative Western blot images and quantitative analysis of CERS1 protein expression in HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL). (n = 3 biological repeats for each group, One-way ANOVA). (I) Representative immunofluorescence images of CD63 (Green) and CERS1 (Yellow) colocalisation in S12 cells treated with 30 μg/mL hucMSC-sEV; nuclei are labelled with DAPI (blue). (Scale bar = 20 μm). (J) Representative immunofluorescence images of CD63 (Green) and CERS1 (Yellow) colocalisation in HPV16-posititve ectocervical organoids (A0X) treated with 30 μg/mL hucMSC-sEV; nuclei are labelled with DAPI (blue). (Scale bar = 20 μm). (K, L) Representative immunofluorescence images and corresponding MFI quantification of CERS1 (red) in S12 cells treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL); nuclei counterstained with DAPI (blue). (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA). (M, N) Representative immunofluorescence images and corresponding MFI quantification of CERS1 (red) in HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL); nuclei counterstained with DAPI (blue). (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA).All data are mean ± SD; In all bar charts, each dot represents one data point; Error bars represent SDs; *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001, ns: no significant.

Journal: Materials Today Bio

Article Title: Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles delivering CERS1 promote squamous differentiation in HPV16-positive cervical intraepithelial neoplasia via remodeling sphingomyelin metabolism

doi: 10.1016/j.mtbio.2026.103801

Figure Lengend Snippet: HucMSC-sEV Delivers CERS1 to S12 Cells and HPV16-positive ectocervical organoids (A) Schematic diagram of de novo and salvage ceramide synthesis pathways, highlighting the role of CERS1 in regulating C18 ceramide synthesis (B) Western blot analysis of CERS1 expression in hucMSCs, hucMSC-sEV, and sEV free CM. (C, D) RT-qPCR analysis of CERS1 mRNA expression in (C) S12 cells and (D) HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL), respectively. (n = 3 biological repeats for each group, One-way ANOVA). (E, F) Representative Western blot images and quantitative analysis of CERS1 protein expression in S12 cells treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL). (n = 3 biological repeats for each group, One-way ANOVA). (G, H) Representative Western blot images and quantitative analysis of CERS1 protein expression in HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL). (n = 3 biological repeats for each group, One-way ANOVA). (I) Representative immunofluorescence images of CD63 (Green) and CERS1 (Yellow) colocalisation in S12 cells treated with 30 μg/mL hucMSC-sEV; nuclei are labelled with DAPI (blue). (Scale bar = 20 μm). (J) Representative immunofluorescence images of CD63 (Green) and CERS1 (Yellow) colocalisation in HPV16-posititve ectocervical organoids (A0X) treated with 30 μg/mL hucMSC-sEV; nuclei are labelled with DAPI (blue). (Scale bar = 20 μm). (K, L) Representative immunofluorescence images and corresponding MFI quantification of CERS1 (red) in S12 cells treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL); nuclei counterstained with DAPI (blue). (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA). (M, N) Representative immunofluorescence images and corresponding MFI quantification of CERS1 (red) in HPV16-posititve ectocervical organoids (A0X) treated with increasing concentrations of hucMSC-sEV (0, 30, 60 μg/mL); nuclei counterstained with DAPI (blue). (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA).All data are mean ± SD; In all bar charts, each dot represents one data point; Error bars represent SDs; *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001, ns: no significant.

Article Snippet: The membranes were blocked with 5% skim milk at room temperature for 1 h, followed by overnight incubation at 4 °C with primary antibodies against IVL (28462-1-AP, 1:2000, Proteintech, Wuhan, China), KRT13 (66684-1-Ig, 1:5000, Proteintech), p53 (sc-71817, 1:100, Santa Cruz Biotechnology, Inc. Dallas, Texas, USA), TGM3 (21406-1-AP, 1:2000, Proteintech), CERS1 (sc-293497, 1:100, Santa Cruz Biotechnology), β-Tubulin (#2146, 1:1000, CST), and GAPDH (#5174, 1:1000, CST).

Techniques: Organoids, Western Blot, Analysis, Expressing, Quantitative RT-PCR, Immunofluorescence

HucMSC-sEV with Knocked-Down CERS1 Downregulate C18 Cer, Inactivate the p53-TGM3 Pathway, and Inhibit Squamous Differentiation in CIN (A) Western blot analysis of CERS1 expression in control sEVs (sEV shCtrl) and CERS1-knockdown sEVs (sEV shCERS1) harvested from engineered HucMSCs. (B-D) Representative immunofluorescence staining images and quantification of MFI for CERS1 (red) in S12 cells/HPV16-posititve ectocervical organoids (AOX) treated with sEV shCtrl or sEV shCERS1. (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA). (E) C18 Cer levels in S12 cells treated with PBS, sEV shCtrl, or sEV shCERS1, measured by LC-MS/MS. (n = 3 biological repeats for each group, One-way ANOVA). (F-J) S12 cells (F, G, I) and HPV16-posititve ectocervical organoids (AOX) (F, H, J) were treated with sEV shCtrl or sEV shCERS1. (F) Representative Western blot images and (I, J) Quantitative analysis of IVL, KRT13, p53, and TGM3 protein expression. (G, H) RT-qPCR analysis of IVL, KRT13, p53, and TGM3 mRNA expression. (n = 3 biological repeats for each group, One-way ANOVA). (K, L) Representative immunofluorescence images and corresponding MFI quantification of IVL (red) in HPV16-posititve ectocervical organoids (A0X) treated with sEV shCtrl or sEV shCERS1. (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA). All data are mean ± SD; In all bar charts, each dot represents one data point; Error bars represent SDs; *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001, ns: no significant.

Journal: Materials Today Bio

Article Title: Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles delivering CERS1 promote squamous differentiation in HPV16-positive cervical intraepithelial neoplasia via remodeling sphingomyelin metabolism

doi: 10.1016/j.mtbio.2026.103801

Figure Lengend Snippet: HucMSC-sEV with Knocked-Down CERS1 Downregulate C18 Cer, Inactivate the p53-TGM3 Pathway, and Inhibit Squamous Differentiation in CIN (A) Western blot analysis of CERS1 expression in control sEVs (sEV shCtrl) and CERS1-knockdown sEVs (sEV shCERS1) harvested from engineered HucMSCs. (B-D) Representative immunofluorescence staining images and quantification of MFI for CERS1 (red) in S12 cells/HPV16-posititve ectocervical organoids (AOX) treated with sEV shCtrl or sEV shCERS1. (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA). (E) C18 Cer levels in S12 cells treated with PBS, sEV shCtrl, or sEV shCERS1, measured by LC-MS/MS. (n = 3 biological repeats for each group, One-way ANOVA). (F-J) S12 cells (F, G, I) and HPV16-posititve ectocervical organoids (AOX) (F, H, J) were treated with sEV shCtrl or sEV shCERS1. (F) Representative Western blot images and (I, J) Quantitative analysis of IVL, KRT13, p53, and TGM3 protein expression. (G, H) RT-qPCR analysis of IVL, KRT13, p53, and TGM3 mRNA expression. (n = 3 biological repeats for each group, One-way ANOVA). (K, L) Representative immunofluorescence images and corresponding MFI quantification of IVL (red) in HPV16-posititve ectocervical organoids (A0X) treated with sEV shCtrl or sEV shCERS1. (Scale bar = 20 μm; n = 3 biological repeats for each group, One-way ANOVA). All data are mean ± SD; In all bar charts, each dot represents one data point; Error bars represent SDs; *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001, ns: no significant.

Article Snippet: The membranes were blocked with 5% skim milk at room temperature for 1 h, followed by overnight incubation at 4 °C with primary antibodies against IVL (28462-1-AP, 1:2000, Proteintech, Wuhan, China), KRT13 (66684-1-Ig, 1:5000, Proteintech), p53 (sc-71817, 1:100, Santa Cruz Biotechnology, Inc. Dallas, Texas, USA), TGM3 (21406-1-AP, 1:2000, Proteintech), CERS1 (sc-293497, 1:100, Santa Cruz Biotechnology), β-Tubulin (#2146, 1:1000, CST), and GAPDH (#5174, 1:1000, CST).

Techniques: Western Blot, Analysis, Expressing, Control, Knockdown, Immunofluorescence, Staining, Organoids, Liquid Chromatography with Mass Spectroscopy, Quantitative RT-PCR

( A ) Schematic diagram of generation of Kat5 d/d mTSCs. The graphic elements were created in BioRender. Wang, F. (2026) https://BioRender.com/k48v0o5 . ( B ) Immunoblot analysis of KAT5 in mTSCs treated with or without Dox for 48 h in Kat5 f/f and Kat5 d/d cells. −Dox indicates untreated controls; +Dox indicates Kat5 depletion. ( C ) Cell counting of mTSCs treated with or without Dox for 48 hours. Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ***P < 0.001. Source data are provided as a source data file. ( D ) Volcano plot of differentially expressed genes (DEGs) ( P < 0.05, log 2 FC ≥ 0.5) in Kat5 f/f and Kat5 d/d mTSCs. ( E ) GO analysis of the top 150 down-regulated DEGs from (D) using DAVID. ( F ) GSEA showing enrichment of chromosome segregation and alignment gene sets in Kat5 d/d mTSCs. ( G ) Immunofluorescent staining of α-tubulin and Lamin A/C in Kat5 f/f and Kat5 d/d mTSCs. Arrows indicate misaligned chromosomes (left) and micronuclei (right). Quantification of metaphase cells with misaligned chromosomes and cells with micronuclei is shown (right). Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ***P < 0.001 and **P < 0.01, respectively. ( H to K ) Immunofluorescence staining and quantification of chromosome misalignment and micronuclei in Kat5 f/f , Kat5 d/d , H2az1 f/f , and H2az1 4M embryos at E5.0 to E5.5. Arrows indicate chromosome misalignment or micronuclei. Quantification was performed in CDX2 + cells ( n = 5 embryos per group for chromosome misalignment; n = 3 embryos per group for micronuclei). Two-tailed unpaired Student’s t test. Error bars, means ± SEM. **P < 0.01, *** P < 0.001.

Journal: Science Advances

Article Title: Loss of KAT5-dependent H2A.Z acetylation provokes chromosomal instability in recurrent pregnancy loss

doi: 10.1126/sciadv.aef6029

Figure Lengend Snippet: ( A ) Schematic diagram of generation of Kat5 d/d mTSCs. The graphic elements were created in BioRender. Wang, F. (2026) https://BioRender.com/k48v0o5 . ( B ) Immunoblot analysis of KAT5 in mTSCs treated with or without Dox for 48 h in Kat5 f/f and Kat5 d/d cells. −Dox indicates untreated controls; +Dox indicates Kat5 depletion. ( C ) Cell counting of mTSCs treated with or without Dox for 48 hours. Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ***P < 0.001. Source data are provided as a source data file. ( D ) Volcano plot of differentially expressed genes (DEGs) ( P < 0.05, log 2 FC ≥ 0.5) in Kat5 f/f and Kat5 d/d mTSCs. ( E ) GO analysis of the top 150 down-regulated DEGs from (D) using DAVID. ( F ) GSEA showing enrichment of chromosome segregation and alignment gene sets in Kat5 d/d mTSCs. ( G ) Immunofluorescent staining of α-tubulin and Lamin A/C in Kat5 f/f and Kat5 d/d mTSCs. Arrows indicate misaligned chromosomes (left) and micronuclei (right). Quantification of metaphase cells with misaligned chromosomes and cells with micronuclei is shown (right). Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ***P < 0.001 and **P < 0.01, respectively. ( H to K ) Immunofluorescence staining and quantification of chromosome misalignment and micronuclei in Kat5 f/f , Kat5 d/d , H2az1 f/f , and H2az1 4M embryos at E5.0 to E5.5. Arrows indicate chromosome misalignment or micronuclei. Quantification was performed in CDX2 + cells ( n = 5 embryos per group for chromosome misalignment; n = 3 embryos per group for micronuclei). Two-tailed unpaired Student’s t test. Error bars, means ± SEM. **P < 0.01, *** P < 0.001.

Article Snippet: Membranes were incubated overnight at 4°C with primary antibodies against KAT5 (Santa Cruz Biotechnology, sc-166323), H2A.Zac (Diagenode, C15410202-50), H4K16ac (Millipore, 07-329), H2A.Z (Abcam, ab4174), α-tubulin (Proteintech, 11224-1-AP), Aurora A (CST, 91590), Aurora B (Abcam, ab2254), CENPA (Abcam, ab45694), followed by incubation with appropriate secondary antibodies at room temperature for 1 hour.

Techniques: Western Blot, Analysis, Cell Counting, Two Tailed Test, Staining, Immunofluorescence, Sublimation

( A ) Immunoblot analysis of H2A.Zac, H2A.Z, and H4K16ac in Kat5 f/f and Kat5 d/d mTSCs. ( B ) Immunofluorescent staining of H2A.Zac in Kat5 f/f and Kat5 d/d mTSCs. ( C ) Heatmap of KAT5 and H2A.Zac CUT&Tag signals centered on transcriptional start sites (TSS). ( D ) Genomic distribution of KAT5 and H2A.Zac peaks in mTSCs. ( E ) Venn diagram showing the overlap among genes whose promoters are bound by KAT5 ( n = 12,949), genes whose promoters are bound by H2A.Zac ( n = 14,039), and genes down-regulated upon Kat5 deletion ( n = 2583). ( F ) GO analysis of the 1719 overlapping genes from (E). ( G ) Quantitative real-time PCR analysis of Top2a , Cdc20 , Aurkb , Aurka , Cenpa , Cenpe , Cdk1 , and Ccnb1 mRNA levels in Kat5 f/f and Kat5 d/d mTSCs. Data are representative of three independent experiments ( n = 3), and the values are normalized to ACTB and indicated as the means ± SEM. Two-tailed unpaired Student’s t test, ** P < 0.01 and *** P < 0.001. Source data are provided as a source data file. ( H ) Immunoblot analysis of KAT5, Aurora A, Aurora B, and CENPA in Kat5 f/f and Kat5 d/d mTSCs. ( I ) Genome browser tracks of KAT5 and H2A.Zac CUT&Tag signals and RNA-seq reads at the Aurka , Aurkb , and Cenpa loci.

Journal: Science Advances

Article Title: Loss of KAT5-dependent H2A.Z acetylation provokes chromosomal instability in recurrent pregnancy loss

doi: 10.1126/sciadv.aef6029

Figure Lengend Snippet: ( A ) Immunoblot analysis of H2A.Zac, H2A.Z, and H4K16ac in Kat5 f/f and Kat5 d/d mTSCs. ( B ) Immunofluorescent staining of H2A.Zac in Kat5 f/f and Kat5 d/d mTSCs. ( C ) Heatmap of KAT5 and H2A.Zac CUT&Tag signals centered on transcriptional start sites (TSS). ( D ) Genomic distribution of KAT5 and H2A.Zac peaks in mTSCs. ( E ) Venn diagram showing the overlap among genes whose promoters are bound by KAT5 ( n = 12,949), genes whose promoters are bound by H2A.Zac ( n = 14,039), and genes down-regulated upon Kat5 deletion ( n = 2583). ( F ) GO analysis of the 1719 overlapping genes from (E). ( G ) Quantitative real-time PCR analysis of Top2a , Cdc20 , Aurkb , Aurka , Cenpa , Cenpe , Cdk1 , and Ccnb1 mRNA levels in Kat5 f/f and Kat5 d/d mTSCs. Data are representative of three independent experiments ( n = 3), and the values are normalized to ACTB and indicated as the means ± SEM. Two-tailed unpaired Student’s t test, ** P < 0.01 and *** P < 0.001. Source data are provided as a source data file. ( H ) Immunoblot analysis of KAT5, Aurora A, Aurora B, and CENPA in Kat5 f/f and Kat5 d/d mTSCs. ( I ) Genome browser tracks of KAT5 and H2A.Zac CUT&Tag signals and RNA-seq reads at the Aurka , Aurkb , and Cenpa loci.

Article Snippet: Membranes were incubated overnight at 4°C with primary antibodies against KAT5 (Santa Cruz Biotechnology, sc-166323), H2A.Zac (Diagenode, C15410202-50), H4K16ac (Millipore, 07-329), H2A.Z (Abcam, ab4174), α-tubulin (Proteintech, 11224-1-AP), Aurora A (CST, 91590), Aurora B (Abcam, ab2254), CENPA (Abcam, ab45694), followed by incubation with appropriate secondary antibodies at room temperature for 1 hour.

Techniques: Western Blot, Analysis, Staining, Real-time Polymerase Chain Reaction, Two Tailed Test, RNA Sequencing

( A ) Quantitative real-time PCR analysis of KAT5 mRNA levels in control ( shNC ) and KAT5 -knockdown ( shKAT5 ) hTSCs. The values are normalized to ACTB. Data are representative of three independent experiments. Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ****P < 0.0001. ( B ) Immunoblot analysis of KAT5 and H2A.Zac in shNC and shKAT5 hTSCs. ( C ) Immunofluorescent staining of H2A.Zac in control and KAT5 -knockdown hTSCs. ( D ) Immunofluorescent staining of α-tubulin and Lamin A/C in control and KAT5 -knockdown hTSCs. Arrows indicate misaligned chromosome (left) and micronuclei (right). ( E ) Quantification of the percentage of cells with chromosome misalignment at metaphase (left) and micronuclei (right) from (D). Data are representative of three independent experiments ( n = 3). Two tailed unpaired Student’s t test. Error bars, means ± SEM. ** P < 0.01 (chromosome misalignment) and ** P < 0.01 (micronuclei). Source data are provided as a source data file. ( F ) Volcano plot of DEGs in KAT5 -knockdown versus control hTSCs ( P < 0.05, log 2 FC ≥ 0.5). ( G ) GO analysis of the top 150 down-regulated DEGs from (F) . ( H and I ) Coverage profiles for KAT5 and H2A.Zac. ( J ) Heatmap of peaks with KAT5 and H2A.Zac centered at TSS. ( K ) Venn diagram showing the overlap among genes with promoters bound by KAT5 ( n = 19,599), bound by H2A.Zac ( n = 23,678), and down-regulated after KAT5 knockdown ( n = 2151). ( L ) GO analysis of the 1719 overlapping genes from (K). ( M ) Genome browser tracks of KAT5 and H2A.Zac CUT&Tag signals and RNA-seq reads at the AURKA , AURKB , and CENPA loci. ( N ) Heatmap of expression levels for KAT5-H2A.Zac target genes involved in chromosome segregation.

Journal: Science Advances

Article Title: Loss of KAT5-dependent H2A.Z acetylation provokes chromosomal instability in recurrent pregnancy loss

doi: 10.1126/sciadv.aef6029

Figure Lengend Snippet: ( A ) Quantitative real-time PCR analysis of KAT5 mRNA levels in control ( shNC ) and KAT5 -knockdown ( shKAT5 ) hTSCs. The values are normalized to ACTB. Data are representative of three independent experiments. Two-tailed unpaired Student’s t test. Error bars, means ± SEM. ****P < 0.0001. ( B ) Immunoblot analysis of KAT5 and H2A.Zac in shNC and shKAT5 hTSCs. ( C ) Immunofluorescent staining of H2A.Zac in control and KAT5 -knockdown hTSCs. ( D ) Immunofluorescent staining of α-tubulin and Lamin A/C in control and KAT5 -knockdown hTSCs. Arrows indicate misaligned chromosome (left) and micronuclei (right). ( E ) Quantification of the percentage of cells with chromosome misalignment at metaphase (left) and micronuclei (right) from (D). Data are representative of three independent experiments ( n = 3). Two tailed unpaired Student’s t test. Error bars, means ± SEM. ** P < 0.01 (chromosome misalignment) and ** P < 0.01 (micronuclei). Source data are provided as a source data file. ( F ) Volcano plot of DEGs in KAT5 -knockdown versus control hTSCs ( P < 0.05, log 2 FC ≥ 0.5). ( G ) GO analysis of the top 150 down-regulated DEGs from (F) . ( H and I ) Coverage profiles for KAT5 and H2A.Zac. ( J ) Heatmap of peaks with KAT5 and H2A.Zac centered at TSS. ( K ) Venn diagram showing the overlap among genes with promoters bound by KAT5 ( n = 19,599), bound by H2A.Zac ( n = 23,678), and down-regulated after KAT5 knockdown ( n = 2151). ( L ) GO analysis of the 1719 overlapping genes from (K). ( M ) Genome browser tracks of KAT5 and H2A.Zac CUT&Tag signals and RNA-seq reads at the AURKA , AURKB , and CENPA loci. ( N ) Heatmap of expression levels for KAT5-H2A.Zac target genes involved in chromosome segregation.

Article Snippet: Membranes were incubated overnight at 4°C with primary antibodies against KAT5 (Santa Cruz Biotechnology, sc-166323), H2A.Zac (Diagenode, C15410202-50), H4K16ac (Millipore, 07-329), H2A.Z (Abcam, ab4174), α-tubulin (Proteintech, 11224-1-AP), Aurora A (CST, 91590), Aurora B (Abcam, ab2254), CENPA (Abcam, ab45694), followed by incubation with appropriate secondary antibodies at room temperature for 1 hour.

Techniques: Real-time Polymerase Chain Reaction, Analysis, Control, Knockdown, Two Tailed Test, Western Blot, Staining, RNA Sequencing, Expressing

IL‐35 Subunit EBI3 is Downregulated in both Obese Mouse Aortas and PA‐Treated HUVECs, and Restored by Exogenous IL‐35. (A, B) Immunofluorescence of EBI3 (red) with CD31 (green) and DAPI (blue) in mouse aortas, with semi‐quantification of fluorescence intensity, n = 3 (scale bar = 50 µM). (C, D) Immunofluorescence of IL‐12A (red) with CD31 (green) and DAPI (blue) in mouse aortas, with semi‐quantification of fluorescence intensity, n = 3 (scale bar = 50 µM). (E) Serum IL‐35 concentrations, n = 8. (F, H) Representative Western blot bands of EBI3 and IL‐12A in aortic tissues (F) and densitometric analysis (H, n = 4). (G, I) Representative Western blot bands of EBI3 and IL‐12A in HUVECs (G) and densitometric analysis (I, n = 4). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐35 Ameliorates Obesity‐Associated Impairment of Endothelium‐Dependent Vasodilation via the STAT3‐MAPK/ERK‐eNOS Signaling Axis

doi: 10.1002/iid3.70564

Figure Lengend Snippet: IL‐35 Subunit EBI3 is Downregulated in both Obese Mouse Aortas and PA‐Treated HUVECs, and Restored by Exogenous IL‐35. (A, B) Immunofluorescence of EBI3 (red) with CD31 (green) and DAPI (blue) in mouse aortas, with semi‐quantification of fluorescence intensity, n = 3 (scale bar = 50 µM). (C, D) Immunofluorescence of IL‐12A (red) with CD31 (green) and DAPI (blue) in mouse aortas, with semi‐quantification of fluorescence intensity, n = 3 (scale bar = 50 µM). (E) Serum IL‐35 concentrations, n = 8. (F, H) Representative Western blot bands of EBI3 and IL‐12A in aortic tissues (F) and densitometric analysis (H, n = 4). (G, I) Representative Western blot bands of EBI3 and IL‐12A in HUVECs (G) and densitometric analysis (I, n = 4). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: Primary antibodies for immunofluorescence and Western blotting: EBI3 (12371‐1‐AP), IL‐12A (85754‐2‐RR), platelet endothelial cell adhesion molecule‐1 (PECAM‐1/CD31) (11265‐1‐AP), eNOS (27120‐1‐AP), and β‐tubulin (66240‐1‐Ig) from Proteintech (USA); p‐eNOS (Ser1177, #9571), p‐cRAF (#9427), p‐MEK1/2 (#9154), and p‐STAT3 (#9145) from Cell Signaling Technology (USA); cRAF (A19638), MEK1/2 (A4868), p‐ERK1/2 (AP0974), ERK1/2 (A4782), and STAT3 (A1192) from ABclonal Technology (China).

Techniques: Immunofluorescence, Fluorescence, Western Blot, Analysis

IL‐35 Restores eNOS Ser1177 phosphorylation and nitric oxide production to enhance endothelium‐dependent relaxation in obesity. (A) Concentration‐response curves of endothelium‐dependent relaxation to ACh and comparison of maximal relaxation (Emax) in mouse aortic rings, n = 4. (B) Concentration‐response curves of endothelium‐independent relaxation to SNP and comparison of Emax, n = 4. (C, D) Western blot bands of p‐eNOS (Ser1177) and total eNOS in mouse aortic tissues (C) and HUVECs (D). (E, F) Densitometric analysis of total eNOS and p‐eNOS (Ser1177)/total eNOS in aortic tissues (E, n = 4) and HUVECs (F, n = 4). (G) NO fluorescence intensity in HUVECs, scale bar = 50 μM. (H) Semi‐quantification of NO fluorescence intensity in HUVECs, n = 3. Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐35 Ameliorates Obesity‐Associated Impairment of Endothelium‐Dependent Vasodilation via the STAT3‐MAPK/ERK‐eNOS Signaling Axis

doi: 10.1002/iid3.70564

Figure Lengend Snippet: IL‐35 Restores eNOS Ser1177 phosphorylation and nitric oxide production to enhance endothelium‐dependent relaxation in obesity. (A) Concentration‐response curves of endothelium‐dependent relaxation to ACh and comparison of maximal relaxation (Emax) in mouse aortic rings, n = 4. (B) Concentration‐response curves of endothelium‐independent relaxation to SNP and comparison of Emax, n = 4. (C, D) Western blot bands of p‐eNOS (Ser1177) and total eNOS in mouse aortic tissues (C) and HUVECs (D). (E, F) Densitometric analysis of total eNOS and p‐eNOS (Ser1177)/total eNOS in aortic tissues (E, n = 4) and HUVECs (F, n = 4). (G) NO fluorescence intensity in HUVECs, scale bar = 50 μM. (H) Semi‐quantification of NO fluorescence intensity in HUVECs, n = 3. Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: Primary antibodies for immunofluorescence and Western blotting: EBI3 (12371‐1‐AP), IL‐12A (85754‐2‐RR), platelet endothelial cell adhesion molecule‐1 (PECAM‐1/CD31) (11265‐1‐AP), eNOS (27120‐1‐AP), and β‐tubulin (66240‐1‐Ig) from Proteintech (USA); p‐eNOS (Ser1177, #9571), p‐cRAF (#9427), p‐MEK1/2 (#9154), and p‐STAT3 (#9145) from Cell Signaling Technology (USA); cRAF (A19638), MEK1/2 (A4868), p‐ERK1/2 (AP0974), ERK1/2 (A4782), and STAT3 (A1192) from ABclonal Technology (China).

Techniques: Phospho-proteomics, Concentration Assay, Comparison, Western Blot, Analysis, Fluorescence

IL‐35 induces the MAPK/ERK signaling pathway, thereby enhancing eNOS Ser1177 phosphorylation and NO production in endothelial cells. (A) Volcano plot of eNOS‐interacting proteins in HUVECs (PA vs. PA + IL‐35) by IP‐mass spectrometry. Red dots: upregulated in PA + IL‐35 group (fold change > 1.5, p < 0.05); MAPK3 (ERK1) is highlighted. (B) STRING‐based PPI network of top 20 binding proteins. ERK1 is the only direct interactor with eNOS. (C) Western blot bands of p‐cRAF, p‐MEK, p‐ERK, p‐eNOS (Ser1177), and total proteins in HUVECs. (D–G) Densitometric analysis of p‐cRAF, p‐MEK, p‐ERK, and p‐eNOS (Ser1177) normalized to total proteins, n = 3. (H, I) NO fluorescence intensity in HUVECs (H, scale bar = 50 μM) with semi‐quantification (I, n = 3). Data are mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐35 Ameliorates Obesity‐Associated Impairment of Endothelium‐Dependent Vasodilation via the STAT3‐MAPK/ERK‐eNOS Signaling Axis

doi: 10.1002/iid3.70564

Figure Lengend Snippet: IL‐35 induces the MAPK/ERK signaling pathway, thereby enhancing eNOS Ser1177 phosphorylation and NO production in endothelial cells. (A) Volcano plot of eNOS‐interacting proteins in HUVECs (PA vs. PA + IL‐35) by IP‐mass spectrometry. Red dots: upregulated in PA + IL‐35 group (fold change > 1.5, p < 0.05); MAPK3 (ERK1) is highlighted. (B) STRING‐based PPI network of top 20 binding proteins. ERK1 is the only direct interactor with eNOS. (C) Western blot bands of p‐cRAF, p‐MEK, p‐ERK, p‐eNOS (Ser1177), and total proteins in HUVECs. (D–G) Densitometric analysis of p‐cRAF, p‐MEK, p‐ERK, and p‐eNOS (Ser1177) normalized to total proteins, n = 3. (H, I) NO fluorescence intensity in HUVECs (H, scale bar = 50 μM) with semi‐quantification (I, n = 3). Data are mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Primary antibodies for immunofluorescence and Western blotting: EBI3 (12371‐1‐AP), IL‐12A (85754‐2‐RR), platelet endothelial cell adhesion molecule‐1 (PECAM‐1/CD31) (11265‐1‐AP), eNOS (27120‐1‐AP), and β‐tubulin (66240‐1‐Ig) from Proteintech (USA); p‐eNOS (Ser1177, #9571), p‐cRAF (#9427), p‐MEK1/2 (#9154), and p‐STAT3 (#9145) from Cell Signaling Technology (USA); cRAF (A19638), MEK1/2 (A4868), p‐ERK1/2 (AP0974), ERK1/2 (A4782), and STAT3 (A1192) from ABclonal Technology (China).

Techniques: Phospho-proteomics, Mass Spectrometry, Binding Assay, Western Blot, Analysis, Fluorescence

IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Journal: Immunity, Inflammation and Disease

Article Title: Interleukin‐35 Ameliorates Obesity‐Associated Impairment of Endothelium‐Dependent Vasodilation via the STAT3‐MAPK/ERK‐eNOS Signaling Axis

doi: 10.1002/iid3.70564

Figure Lengend Snippet: IL‐35 activates the STAT3‐MAPK/ERK‐eNOS signaling axis to promote eNOS phosphorylation and NO production in endothelial cells. (A) Western blot bands of p‐STAT3, p‐eNOS (Ser1177), p‐cRAF, p‐MEK, p‐ERK, and corresponding total proteins in HUVECs. (B–I) Densitometric analysis of p‐STAT3, STAT3, p‐eNOS (Ser1177), eNOS, p‐cRAF, p‐MEK, and p‐ERK normalized to total proteins or β‐tubulin, n = 3. (J–K) NO fluorescence intensity in HUVECs (J, scale bar = 50 μM) with semi‐quantification (K, n = 3). Data are mean ± SD. ns, not significant; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: Primary antibodies for immunofluorescence and Western blotting: EBI3 (12371‐1‐AP), IL‐12A (85754‐2‐RR), platelet endothelial cell adhesion molecule‐1 (PECAM‐1/CD31) (11265‐1‐AP), eNOS (27120‐1‐AP), and β‐tubulin (66240‐1‐Ig) from Proteintech (USA); p‐eNOS (Ser1177, #9571), p‐cRAF (#9427), p‐MEK1/2 (#9154), and p‐STAT3 (#9145) from Cell Signaling Technology (USA); cRAF (A19638), MEK1/2 (A4868), p‐ERK1/2 (AP0974), ERK1/2 (A4782), and STAT3 (A1192) from ABclonal Technology (China).

Techniques: Phospho-proteomics, Western Blot, Analysis, Fluorescence

Clinical significance of the TUBB2A and TUBB3 target genes in breast cancer patients. ( A ) Kaplan–Meier plots correlating gene-chip mRNA expression of TUBB2A and TUBB3 to the survival of breast cancer patients ( n = 4929). High expression of both isotypes was associated with worse survival ( TUBB2A , HR 1.39; TUBB3 , HR 1.57). Plots were generated using KM Plotter ( https://kmplot.com/analysis/ , accessed on 20 January 2026), including all breast cancer subtypes without restriction by treatment. Patients stratified at the median. ( B ) Immunohistochemistry of normal human mammary gland tissue sections, stained for tubulin β2 and β3. Strong β2 staining but not β3 was observed in the epithelial lining cells of the mammary ducts. Representative of 5 images per marker. Images captured at 40×, scale bar 50 µm. ( C ) Expression of TUBB2A and TUBB3 (log 2 [TPM + 1]) in BRCA tumors (red) versus normal (blue) breast tissue. Tumor samples demonstrated significant downregulation of TUBB2A and upregulation of TUBB3 ( n = 1093 tumor, n = 112 normal; *** p < 0.001). Analyzed using TIMER2.0 ( http://timer.cistrome.org/ , accessed on 14 January 2026). TPM: Transcripts per million.

Journal: Cancers

Article Title: A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells

doi: 10.3390/cancers18213418

Figure Lengend Snippet: Clinical significance of the TUBB2A and TUBB3 target genes in breast cancer patients. ( A ) Kaplan–Meier plots correlating gene-chip mRNA expression of TUBB2A and TUBB3 to the survival of breast cancer patients ( n = 4929). High expression of both isotypes was associated with worse survival ( TUBB2A , HR 1.39; TUBB3 , HR 1.57). Plots were generated using KM Plotter ( https://kmplot.com/analysis/ , accessed on 20 January 2026), including all breast cancer subtypes without restriction by treatment. Patients stratified at the median. ( B ) Immunohistochemistry of normal human mammary gland tissue sections, stained for tubulin β2 and β3. Strong β2 staining but not β3 was observed in the epithelial lining cells of the mammary ducts. Representative of 5 images per marker. Images captured at 40×, scale bar 50 µm. ( C ) Expression of TUBB2A and TUBB3 (log 2 [TPM + 1]) in BRCA tumors (red) versus normal (blue) breast tissue. Tumor samples demonstrated significant downregulation of TUBB2A and upregulation of TUBB3 ( n = 1093 tumor, n = 112 normal; *** p < 0.001). Analyzed using TIMER2.0 ( http://timer.cistrome.org/ , accessed on 14 January 2026). TPM: Transcripts per million.

Article Snippet: Tubulin isotypes were probed using antibodies against total α-tubulin (monoclonal; Cell Signaling Technology, Danvers, MA, USA, #3873), tubulin α1a (polyclonal; Abcam, Waltham, MA, USA, ab95966), tubulin α1b (monoclonal; Abcam, Waltham, MA, USA, ab108629), tubulin α8 (monoclonal; Novus, Minneapolis, MN, USA, NBP2-37535), tubulin β1 (monoclonal; Abcam, Waltham, MA, USA, ab179511), tubulin β2 (monoclonal; Santa Cruz, Dallas, TX, USA, sc-47751; WB), tubulin β2 (monoclonal; Abcam, Waltham, MA, USA, #ab179512; IHC), tubulin β3 (monoclonal; BioLegend 801213), tubulin β4 (monoclonal; Abcam, Waltham, MA, USA, ab179509), tubulin β6 (monoclonal; Abcam, Waltham, MA, USA, ab322871), tubulin β8 (polyclonal; Novus, Minneapolis, MN, USA, NBP3-05594), and tubulin γ1 (monoclonal; Abcam, Waltham, MA, USA, ab129021).

Techniques: Expressing, Generated, Analysis, Immunohistochemistry, Tissue, Staining, Marker

Tubulin β2 and β3 abundance in matched bone-metastatic tumors. ( A ) Immunohistochemistry assessing differential staining of microtubule isotypes between matched primary and bone-metastatic breast tumors ( n = 16). From left to right are 4×, 20×, and 40× images. Dashed squares represent areas captured at higher magnifications. Symbols shown are identified as: T (tumor), B (bone), TC (tumor cell). Stained for tubulin β2 top (Abcam #ab179512) and tubulin β3 bottom (Biolegend #801213). ( B ) Analyzed 269 images. Tubulin β2 (237 40× images) and tubulin β3 (32 20× images) staining intensity distribution in primary breast tumors versus matched bone-metastatic lesions ( n = 16 patients). Stacked bars depict the percentage of pooled cells (all patients combined) separated into each of the four staining-intensity categories (Negative, Weak, Moderate, Strong). Statistical analysis performed using two-way ANOVA demonstrated a main effect of tissue type (primary vs. bone metastasis; p = 0.03) for tubulin β2, but no significant main effect for tubulin β3. IHC analysis revealed increased tubulin β2 and tubulin-β3-positive cell populations in bone-metastatic lesions relative to primary breast tumors, with strongly positive cells elevated 1.7-fold (9.4% vs. 16.2%) in tubulin β2 and 2.22-fold (2.6% vs. 5.9%) in tubulin β3.

Journal: Cancers

Article Title: A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells

doi: 10.3390/cancers18213418

Figure Lengend Snippet: Tubulin β2 and β3 abundance in matched bone-metastatic tumors. ( A ) Immunohistochemistry assessing differential staining of microtubule isotypes between matched primary and bone-metastatic breast tumors ( n = 16). From left to right are 4×, 20×, and 40× images. Dashed squares represent areas captured at higher magnifications. Symbols shown are identified as: T (tumor), B (bone), TC (tumor cell). Stained for tubulin β2 top (Abcam #ab179512) and tubulin β3 bottom (Biolegend #801213). ( B ) Analyzed 269 images. Tubulin β2 (237 40× images) and tubulin β3 (32 20× images) staining intensity distribution in primary breast tumors versus matched bone-metastatic lesions ( n = 16 patients). Stacked bars depict the percentage of pooled cells (all patients combined) separated into each of the four staining-intensity categories (Negative, Weak, Moderate, Strong). Statistical analysis performed using two-way ANOVA demonstrated a main effect of tissue type (primary vs. bone metastasis; p = 0.03) for tubulin β2, but no significant main effect for tubulin β3. IHC analysis revealed increased tubulin β2 and tubulin-β3-positive cell populations in bone-metastatic lesions relative to primary breast tumors, with strongly positive cells elevated 1.7-fold (9.4% vs. 16.2%) in tubulin β2 and 2.22-fold (2.6% vs. 5.9%) in tubulin β3.

Article Snippet: Tubulin isotypes were probed using antibodies against total α-tubulin (monoclonal; Cell Signaling Technology, Danvers, MA, USA, #3873), tubulin α1a (polyclonal; Abcam, Waltham, MA, USA, ab95966), tubulin α1b (monoclonal; Abcam, Waltham, MA, USA, ab108629), tubulin α8 (monoclonal; Novus, Minneapolis, MN, USA, NBP2-37535), tubulin β1 (monoclonal; Abcam, Waltham, MA, USA, ab179511), tubulin β2 (monoclonal; Santa Cruz, Dallas, TX, USA, sc-47751; WB), tubulin β2 (monoclonal; Abcam, Waltham, MA, USA, #ab179512; IHC), tubulin β3 (monoclonal; BioLegend 801213), tubulin β4 (monoclonal; Abcam, Waltham, MA, USA, ab179509), tubulin β6 (monoclonal; Abcam, Waltham, MA, USA, ab322871), tubulin β8 (polyclonal; Novus, Minneapolis, MN, USA, NBP3-05594), and tubulin γ1 (monoclonal; Abcam, Waltham, MA, USA, ab129021).

Techniques: Immunohistochemistry, Staining, Analysis, Tissue

Generation and characterization of tubulin β2a- and β3-deficient cells. ( A ) Western blot analysis of tubulin β2a and tubulin β3 expression in scramble, TUBB2A KO, and TUBB3 KD cells. Tubulin β2a was markedly reduced in TUBB2A KO cells (**** p < 0.0001, n = 4), while tubulin β3 showed a modest reduction in TUBB3 KD cells ( p = 0.1171, n = 3). Quantification represents fold change relative to scramble with β-actin serving as a loading control. One-way ANOVA. ( B ) Quantitative PCR analysis comparing β-tubulin isotype expression ( TUBΒ1 , TUBB2A , TUBΒ2B , TUBB3 , TUBB4A , and TUBΒ6 ). Gene expression was calculated using the ΔΔCt method normalized to an average of 2 housekeeping genes (ACTB and GAPDH) and is presented as fold change relative to scramble. TUBB2A KO cells demonstrated reduced TUBB2A and TUBΒ2B with increased TUBB4A . Bars represent mean ± standard deviation; symbols represent individual biological samples ( n = 4–5). Two-way ANOVA. ( C ) Western blot analysis of β-tubulin isotype protein expression (tubulin β1, β4, β6, β8) revealed no significant changes. Quantification represents fold change relative to scramble ( n = 4) with β-actin serving as loading control. One-way ANOVA. ( D ) Cell cycle distribution was assessed by flow cytometry quantified across sub-G1, G1, S, and G2/M populations. TUBB3 KD cells showed a significant reduction in the G2/M population relative to scramble control, with an accumulation in the sub-G1 and G1 populations, consistent with impaired progression through cell division. Data represent mean ± SD of n = 4 independent experiments. Two-way ANOVA. ( E ) Microtubule regrowth assay demonstrated impaired regrowth in both TUBB2A KO and TUBB3 KD cells. Representative images at 5- and 30 min recovery ( left ) and ImageJ quantification of mean aster area per image ( right ). At 5 min, aster area was comparable across all genotypes indicating intact nucleation. At 30 min, regrowth was severely impaired in TUBB2A KO (~5% of scramble) and TUBB3 KD (~4% of scramble). Aster area was measured in a total of 513 cells across 44 images (Scramble, 174; TUBB2A KO, 147; TUBB3 KD, 192). Per-image means were used as the unit of analysis. Bar graph represents mean ± SD of per-image means. Two-way ANOVA. All ANOVA analyses were performed with Dunnett’s multiple-comparison analysis. All statistical levels are denoted as follows: * p < 0.05, ** p < 0.01, **** p < 0.0001. For original WB Figures please see .

Journal: Cancers

Article Title: A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells

doi: 10.3390/cancers18213418

Figure Lengend Snippet: Generation and characterization of tubulin β2a- and β3-deficient cells. ( A ) Western blot analysis of tubulin β2a and tubulin β3 expression in scramble, TUBB2A KO, and TUBB3 KD cells. Tubulin β2a was markedly reduced in TUBB2A KO cells (**** p < 0.0001, n = 4), while tubulin β3 showed a modest reduction in TUBB3 KD cells ( p = 0.1171, n = 3). Quantification represents fold change relative to scramble with β-actin serving as a loading control. One-way ANOVA. ( B ) Quantitative PCR analysis comparing β-tubulin isotype expression ( TUBΒ1 , TUBB2A , TUBΒ2B , TUBB3 , TUBB4A , and TUBΒ6 ). Gene expression was calculated using the ΔΔCt method normalized to an average of 2 housekeeping genes (ACTB and GAPDH) and is presented as fold change relative to scramble. TUBB2A KO cells demonstrated reduced TUBB2A and TUBΒ2B with increased TUBB4A . Bars represent mean ± standard deviation; symbols represent individual biological samples ( n = 4–5). Two-way ANOVA. ( C ) Western blot analysis of β-tubulin isotype protein expression (tubulin β1, β4, β6, β8) revealed no significant changes. Quantification represents fold change relative to scramble ( n = 4) with β-actin serving as loading control. One-way ANOVA. ( D ) Cell cycle distribution was assessed by flow cytometry quantified across sub-G1, G1, S, and G2/M populations. TUBB3 KD cells showed a significant reduction in the G2/M population relative to scramble control, with an accumulation in the sub-G1 and G1 populations, consistent with impaired progression through cell division. Data represent mean ± SD of n = 4 independent experiments. Two-way ANOVA. ( E ) Microtubule regrowth assay demonstrated impaired regrowth in both TUBB2A KO and TUBB3 KD cells. Representative images at 5- and 30 min recovery ( left ) and ImageJ quantification of mean aster area per image ( right ). At 5 min, aster area was comparable across all genotypes indicating intact nucleation. At 30 min, regrowth was severely impaired in TUBB2A KO (~5% of scramble) and TUBB3 KD (~4% of scramble). Aster area was measured in a total of 513 cells across 44 images (Scramble, 174; TUBB2A KO, 147; TUBB3 KD, 192). Per-image means were used as the unit of analysis. Bar graph represents mean ± SD of per-image means. Two-way ANOVA. All ANOVA analyses were performed with Dunnett’s multiple-comparison analysis. All statistical levels are denoted as follows: * p < 0.05, ** p < 0.01, **** p < 0.0001. For original WB Figures please see .

Article Snippet: Tubulin isotypes were probed using antibodies against total α-tubulin (monoclonal; Cell Signaling Technology, Danvers, MA, USA, #3873), tubulin α1a (polyclonal; Abcam, Waltham, MA, USA, ab95966), tubulin α1b (monoclonal; Abcam, Waltham, MA, USA, ab108629), tubulin α8 (monoclonal; Novus, Minneapolis, MN, USA, NBP2-37535), tubulin β1 (monoclonal; Abcam, Waltham, MA, USA, ab179511), tubulin β2 (monoclonal; Santa Cruz, Dallas, TX, USA, sc-47751; WB), tubulin β2 (monoclonal; Abcam, Waltham, MA, USA, #ab179512; IHC), tubulin β3 (monoclonal; BioLegend 801213), tubulin β4 (monoclonal; Abcam, Waltham, MA, USA, ab179509), tubulin β6 (monoclonal; Abcam, Waltham, MA, USA, ab322871), tubulin β8 (polyclonal; Novus, Minneapolis, MN, USA, NBP3-05594), and tubulin γ1 (monoclonal; Abcam, Waltham, MA, USA, ab129021).

Techniques: Western Blot, Analysis, Expressing, Control, Real-time Polymerase Chain Reaction, Gene Expression, Standard Deviation, Flow Cytometry, Regrowth Assay, Comparison

Tubulin-deficient MDA-MB-231 cells exhibit altered substrate adhesion and focal adhesion protein expression. ( A ) Representative scanned image of 12-well plates following crystal violet staining of adherent MDA-MB-231 cells. Cells were seeded as 50,000-cell droplets in 50 µL onto tissue culture plastic, collagen I, or fibronectin. After 2 h, wells were washed to remove non-adherent cells, and remaining adherent cells were stained with crystal violet. ( B ) Quantification of crystal violet staining following solubilization in acetic acid and absorbance measurement at 560 nm. Data are presented as fold change relative to scramble control; symbols represent individual biological samples ( n = 3–4). Error bars indicate standard deviation. Statistical significance was determined using one-way ANOVA followed by Dunnett’s multiple-comparisons; * p < 0.05, ** p < 0.01. ( C ) Schematic illustrating interactions among microtubules (MT), actin, focal adhesion complexes, and endosomal trafficking pathways that collectively regulate cell adhesion and signaling; the red circle indicates phosphorylated focal adhesion kinase (FAK), and blue symbols represent MT–actin crosslinking proteins. Loss or reduction of TUBB2A or TUBB3 may disrupt coordination between these networks. ( D ) Western blot analysis of focal adhesion-associated proteins. TUBB2A KO cells showed increased integrin β5 and α5, while TUBB3 KD increased integrin β5, α4, and talin. Quantification represents fold change relative to scramble, with β-actin serving as a loading control. Bars represent mean ± SD of n = 3–7 independent sample sets. One-way ANOVA with Dunnett’s multiple-comparisons test; * p < 0.05. For original WB Figures please see .

Journal: Cancers

Article Title: A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells

doi: 10.3390/cancers18213418

Figure Lengend Snippet: Tubulin-deficient MDA-MB-231 cells exhibit altered substrate adhesion and focal adhesion protein expression. ( A ) Representative scanned image of 12-well plates following crystal violet staining of adherent MDA-MB-231 cells. Cells were seeded as 50,000-cell droplets in 50 µL onto tissue culture plastic, collagen I, or fibronectin. After 2 h, wells were washed to remove non-adherent cells, and remaining adherent cells were stained with crystal violet. ( B ) Quantification of crystal violet staining following solubilization in acetic acid and absorbance measurement at 560 nm. Data are presented as fold change relative to scramble control; symbols represent individual biological samples ( n = 3–4). Error bars indicate standard deviation. Statistical significance was determined using one-way ANOVA followed by Dunnett’s multiple-comparisons; * p < 0.05, ** p < 0.01. ( C ) Schematic illustrating interactions among microtubules (MT), actin, focal adhesion complexes, and endosomal trafficking pathways that collectively regulate cell adhesion and signaling; the red circle indicates phosphorylated focal adhesion kinase (FAK), and blue symbols represent MT–actin crosslinking proteins. Loss or reduction of TUBB2A or TUBB3 may disrupt coordination between these networks. ( D ) Western blot analysis of focal adhesion-associated proteins. TUBB2A KO cells showed increased integrin β5 and α5, while TUBB3 KD increased integrin β5, α4, and talin. Quantification represents fold change relative to scramble, with β-actin serving as a loading control. Bars represent mean ± SD of n = 3–7 independent sample sets. One-way ANOVA with Dunnett’s multiple-comparisons test; * p < 0.05. For original WB Figures please see .

Article Snippet: Tubulin isotypes were probed using antibodies against total α-tubulin (monoclonal; Cell Signaling Technology, Danvers, MA, USA, #3873), tubulin α1a (polyclonal; Abcam, Waltham, MA, USA, ab95966), tubulin α1b (monoclonal; Abcam, Waltham, MA, USA, ab108629), tubulin α8 (monoclonal; Novus, Minneapolis, MN, USA, NBP2-37535), tubulin β1 (monoclonal; Abcam, Waltham, MA, USA, ab179511), tubulin β2 (monoclonal; Santa Cruz, Dallas, TX, USA, sc-47751; WB), tubulin β2 (monoclonal; Abcam, Waltham, MA, USA, #ab179512; IHC), tubulin β3 (monoclonal; BioLegend 801213), tubulin β4 (monoclonal; Abcam, Waltham, MA, USA, ab179509), tubulin β6 (monoclonal; Abcam, Waltham, MA, USA, ab322871), tubulin β8 (polyclonal; Novus, Minneapolis, MN, USA, NBP3-05594), and tubulin γ1 (monoclonal; Abcam, Waltham, MA, USA, ab129021).

Techniques: Expressing, Crystal Violet Assay, Tissue, Staining, Control, Standard Deviation, Western Blot, Analysis